Jim Sergi

Mr. Jim Sergi is President of CSSi LifeSciences, a global CRO that specializes in advancing drugs and medical technologies from discovery to commercialization. He was the Founder and Managing Partner of Bay Tower Capital, a life sciences merchant bank and the Founder and CEO of ProED Communications, a healthcare services and drug development company. He is directly responsible for over 85 FDA approvals and over 250 medical device approvals. He serves as Director of Experimental Therapeutics at the Cleveland Clinic Cancer Center, Associate Professor of Medical-Surgical Nursing at the Case Western Reserve University and Lecturer for Oncology at Cleveland State University. He serves as scientific reviewer for the NIH SBIR/STTR Programs and a scientific advisor and board member to numerous nonprofits, private equity and venture backed investment firms. He received his MS degree in Health Care Administration from Cleveland State University and MS degree in Nursing from University of Akron.